Hx-Etoposide 400mg/20ml Namibia - English - Namibia Medicines Regulatory Council

hx-etoposide 400mg/20ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 20ml solution contains etoposide 400.0 mg

Hx-Etoposide 50mg/2.5ml Namibia - English - Namibia Medicines Regulatory Council

hx-etoposide 50mg/2.5ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 2.5ml solution contains etoposide 50.0 mg

Hx-Etoposide 200mg/10ml Namibia - English - Namibia Medicines Regulatory Council

hx-etoposide 200mg/10ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 10ml solution contains etoposide 200.0 mg

ETOPOSIDE INJECTION LIQUID Canada - English - Health Canada

etoposide injection liquid

fresenius kabi canada ltd - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents

ETOPOSIDE INJECTION LIQUID Canada - English - Health Canada

etoposide injection liquid

teva canada limited - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents

ETOPOSIDE INJECTION, USP SOLUTION Canada - English - Health Canada

etoposide injection, usp solution

strides pharma canada inc - etoposide - solution - 20mg - etoposide 20mg - antineoplastic agents

Pfizer (Australia) ETOPOSIDE 20mg/mL injection vial multidose Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (australia) etoposide 20mg/ml injection vial multidose

pfizer australia pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - indications as at 3 april 1996: etoposide injection is indicated for the following: small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia. hodgkin's disease. non-hodgkin's lymphoma

TOPOSAR etoposide injection solution concentrate United States - English - NLM (National Library of Medicine)

toposar etoposide injection solution concentrate

teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml

ETOPOPHOS etoposide 1g (as phosphate) powder for  injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

etopophos etoposide 1g (as phosphate) powder for injection vial

link medical products pty ltd t/a link pharmaceuticals - etoposide phosphate, quantity: 1136 mg (equivalent: etoposide, qty 1000 mg) - injection, powder for - excipient ingredients: sodium citrate dihydrate; dextran 40 - indications: for use in the treatment of: *small cell carcinoma of the lung *acute monocytic and myelomonocytic leukaemia *hodgkin's disease *non-hodgkin's lymphoma *testicular tumours.